Detailed answers about UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED, including incorporation, status, business activity, and accounts information.
When was UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED founded?
UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED was officially incorporated on 13 August 2008 and is registered under company number 06672185. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED?
UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED do?
UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED operates in the following sector: 94990 - Activities of other membership organizations n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED's registered address?
The registered office address of UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED is STARLING HOUSE, 1600 BRISTOL PARKWAY NORTH, NEWBRICK ROAD, BRISTOL, ENGLAND, BS34 8YU. This is the official address filed with Companies House for legal and statutory correspondence.
Is UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED financially stable?
The most recent accounts for UK AND IRELAND NEUROENDOCRINE TUMOUR SOCIETY LIMITED were made up to 31 August 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 May 2026.